Met Life Investment Management, LLC Exact Sciences Corp Transaction History

Met Life Investment Management, LLC

$20.1 Billion
Q3 2025

A detailed history of Met Life Investment Management, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Met Life Investment Management, LLC holds 3,592 shares of EXAS stock, worth $240,771. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,592

Previous 3,569 0.64%

Holding current value

$240,771

Previous $189,000 3.7%

% of portfolio

0.0%

Previous 0.0%

50 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$40.91 - $56.0 $940 - $1,288	23 Added 0.64%	3,592 $196,000
Q2 2025 Aug 13, 2025	SELL	$40.31 - $58.08 $114,722 - $165,295	-2,846 Reduced 44.36%	3,569 $189,000
Q1 2025 May 14, 2025	BUY	$43.04 - $58.51 $1,506 - $2,047	35 Added 0.55%	6,415 $277,000
Q4 2024 Feb 13, 2025	SELL	$49.33 - $71.97 $4,686 - $6,837	-95 Reduced 1.47%	6,380 $358,000
Q3 2024 Nov 13, 2024	SELL	$42.43 - $70.83 $5,643 - $9,420	-133 Reduced 2.01%	6,475 $440,000

Q2 2024 Aug 13, 2024	BUY	$41.33 - $74.26 $23,392 - $42,031	566 Added 9.37%	6,608 $279,000
Q1 2024 May 14, 2024	BUY	$56.27 - $73.77 $339,983 - $445,718	6,042 New	6,042 $417,000
Q4 2023 Feb 14, 2024	SELL	$59.06 - $75.72 $5,610 - $7,193	-95 Reduced 1.55%	6,025 $445,000
Q3 2023 May 09, 2024	BUY	$65.94 - $99.04 $81,633 - $122,611	1,238 Added 25.36%	6,120 $417,000
Q3 2023 Apr 29, 2024	BUY	$65.94 - $99.04 $329 - $495	5 Added 0.08%	6,120 $417,000
Q3 2023 Nov 14, 2023	BUY	$65.94 - $99.04 $329 - $495	5 Added 0.08%	6,120 $417,000
Q2 2023 Apr 29, 2024	BUY	$62.68 - $95.05 $383,288 - $581,230	6,115 New	6,115 $574,000
Q2 2023 Aug 10, 2023	BUY	$62.68 - $95.05 $77,284 - $117,196	1,233 Added 25.26%	6,115 $574,000
Q1 2023 May 09, 2024	BUY	$47.19 - $70.77 $230,381 - $345,499	4,882 New	4,882 $331 Million
Q1 2023 May 15, 2023	BUY	$47.19 - $70.77 $519 - $778	11 Added 0.23%	4,882 $331,000
Q4 2022 May 10, 2024	SELL	$30.35 - $53.15 $1,092 - $1,913	-36 Reduced 0.73%	4,871 $241,000
Q4 2022 Jun 14, 2023	SELL	$30.35 - $53.15 $333 - $584	-11 Reduced 0.23%	4,871 $241,000
Q4 2022 Mar 22, 2023	SELL	$30.35 - $53.15 $1,092 - $1,913	-36 Reduced 0.73%	4,871 $241,000
Q4 2022 Feb 15, 2023	SELL	$30.35 - $53.15 $1,092 - $1,913	-36 Reduced 0.73%	4,871 $241,000
Q3 2022 May 10, 2024	SELL	$31.97 - $49.37 $2,237 - $3,455	-70 Reduced 1.41%	4,907 $159,000
Q3 2022 Jun 14, 2023	BUY	$31.97 - $49.37 $799 - $1,234	25 Added 0.51%	4,907 $159,000
Q3 2022 Mar 22, 2023	SELL	$31.97 - $49.37 $2,237 - $3,455	-70 Reduced 1.41%	4,907 $159,000
Q3 2022 Nov 14, 2022	SELL	$31.97 - $49.37 $2,237 - $3,455	-70 Reduced 1.41%	4,907 $159,000
Q2 2022 May 10, 2024	SELL	$35.61 - $76.23 $200,448 - $429,098	-5,629 Reduced 53.07%	4,977 $196,000
Q2 2022 Jun 20, 2023	BUY	$35.61 - $76.23 $3,382 - $7,241	95 Added 1.95%	4,977 $196,000
Q2 2022 Mar 22, 2023	SELL	$35.61 - $76.23 $200,448 - $429,098	-5,629 Reduced 53.07%	4,977 $196,000
Q2 2022 Aug 11, 2022	SELL	$35.61 - $76.23 $200,448 - $429,098	-5,629 Reduced 53.07%	4,977 $196,000
Q1 2022 May 10, 2024	BUY	$57.56 - $82.54 $610,481 - $875,419	10,606 New	10,606 $741,000
Q1 2022 Jun 20, 2023	BUY	$57.56 - $82.54 $329,473 - $472,458	5,724 Added 117.25%	10,606 $741,000
Q1 2022 Mar 22, 2023	BUY	$57.56 - $82.54 $595,861 - $854,454	10,352 Added 4075.59%	10,606 $741,000
Q1 2022 May 12, 2022	BUY	$57.56 - $82.54 $610,481 - $875,419	10,606 New	10,606 $742,000
Q4 2021 Feb 15, 2022	SELL	$72.5 - $100.68 $18,415 - $25,572	-254 Closed	0 $0
Q3 2021 Mar 22, 2023	SELL	$90.24 - $124.05 $12,633 - $17,367	-140 Reduced 35.53%	254 $24,000
Q3 2021 Nov 15, 2021	BUY	$90.24 - $124.05 $22,920 - $31,508	254 New	254 $24,000
Q2 2021 Aug 16, 2021	SELL	$93.66 - $139.27 $36,902 - $54,872	-394 Closed	0 $0
Q1 2021 Mar 22, 2023	BUY	$116.57 - $155.01 $26,811 - $35,652	230 Added 140.24%	394 $51,000
Q1 2021 May 14, 2021	BUY	$116.57 - $155.01 $45,928 - $61,073	394 New	394 $52,000
Q2 2019 Aug 14, 2019	SELL	$89.51 - $118.04 $14,679 - $19,358	-164 Closed	0 $0
Q1 2019 Jul 13, 2023	SELL	$61.98 - $96.5 $292,421 - $455,287	-4,718 Reduced 96.64%	164 $14,000
Q1 2019 Mar 22, 2023	BUY	$61.98 - $96.5 $61 - $96	1 Added 0.61%	164 $14,000
Q1 2019 May 15, 2019	BUY	$61.98 - $96.5 $61 - $96	1 Added 0.61%	164 $14,000
Q4 2018 Jul 13, 2023	SELL	$56.04 - $82.66 $264,452 - $390,072	-4,719 Reduced 96.66%	163 $10,000
Q4 2018 Mar 22, 2023	SELL	$56.04 - $82.66 $112 - $165	-2 Reduced 1.21%	163 $10,000
Q4 2018 Feb 14, 2019	SELL	$56.04 - $82.66 $112 - $165	-2 Reduced 1.21%	163 $10,000
Q3 2018 Jul 13, 2023	SELL	$48.29 - $80.6 $227,783 - $380,190	-4,717 Reduced 96.62%	165 $13,000
Q3 2018 Mar 22, 2023	SELL	$48.29 - $80.6 $227,252 - $379,303	-4,706 Reduced 96.61%	165 $13,000
Q3 2018 Nov 14, 2018	BUY	$48.29 - $80.6 $7,967 - $13,298	165 New	165 $13,000
Q2 2018 Aug 15, 2018	SELL	$37.84 - $69.96 $1.98 Million - $3.66 Million	-52,309 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$39.82 - $57.53 $80,555 - $116,383	-2,023 Reduced 3.72%	52,309 $2.11 Million
Q4 2017 Feb 15, 2018	BUY	$46.49 - $60.51 $2.53 Million - $3.29 Million	54,332	54,332 $2.86 Million

Others Institutions Holding EXAS

# of Institutions

670

Shares Held

164M

Call Options Held

2.2M

Put Options Held

1.69M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $11.9B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account

Met Life Investment Management, LLC Exact Sciences Corp Transaction History